Citations for
Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.
Jorgensen AL, FitzGerald RJ, Oyee J, Pirmohamed M, Williamson PR.
PLoS One 7(8):e44064. doi: 10.1371/journal.pone.0044064. Epub 2012 Aug 29. Review. 2012
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
Takeuchi F, McGinnis R, Bourgeois S, Barnes C, Eriksson N, Soranzo N, Whittaker P, Ranganath V, Kumanduri V, McLaren W, Holm L, Lindh J, Rane A, Wadelius M, Deloukas P.
PLoS Genet 5(3):e1000433. Epub 2009 Mar 20. 2009
Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.
Scott SA, Edelmann L, Kornreich R, Desnick RJ.
Am J Hum Genet 82(2):495-500. Epub 2008 Jan 17. 2008
Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation.
Li T, Lange LA, Li X, Susswein L, Bryant B, Malone R, Lange EM, Huang TY, Stafford DW, Evans JP.
J Med Genet 43(9):740-4. Epub 2006 Apr 12. 2006
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
Schwarz UI.
Eur J Clin Invest 33 Suppl 2:23-30. Review. 2003
Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.
Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ.
J Biol Chem 277(28):25125-32. 2002
7CYP2C18, CYP2C19, CYP2C8, CYP2C9
The human CYP2C locus: a prototype for intergenic and exon repetition splicing events.
Finta C, Zaphiropoulos PG.
Genomics 63(3):433-438. 2000
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.
Miners JO, Birkett DJ.
Br J Clin Pharmacol 45(6):525-38. Review. 1998
9CYP24A1, CYP26A1, CYP27A1, CYP27B1, CYP2A, CYP2@, CYP2A13, CYP2A6, CYP2A7, CYP2A7P1, CYP2B, CYP2B6, CYP2B7P1, CYP2C@, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D@, CYP2D6, CYP2D7P1, CYP2D7P2, CYP2D8P1, CYP2D8P2, CYP2E1, CYP2F1, CYP2F1P, CYP2G1P, CYP2G2P, CYP2J2, CYP2S1, CYP2T2P, CYP2T3P
Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
Smith G, Stubbins MJ, Harries LW, Wolf CR.
Xenobiotica 28(12):1129-65. Review. No abstract available. 1998
10CYP2C18, CYP2C19, CYP2C8, CYP2C9
A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.
Gray IC, Nobile C, Muresu R, Ford S, Spurr NK.
Genomics 28(2):328-32. 1995
11CYP2C18, CYP2C19, CYP2C8, CYP2C9
Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1.
Inoue K, et al.
Jpn J Hum Genet 39 : 337-343. 1994
12CYP2C18, CYP2C9
Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18.
de Morais SM, Schweikl H, Blaisdell J, Goldstein JA.
Biochem Biophys Res Commun 194(1):194-201. 1993
Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity.
Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T.
Biochem Int 27(6):1073-81. 1992
14CYP2C9, CYP2C19
Cloning and expression of complementary DNAs for multiple members of the human cytochromosome P450IIC subfamily.
Romkes M, et al.
Biochemistry 30 : 3247-3255. 1991
Human cytochrome P-450 PB-I : a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10.
Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.
Am J Hum Genet 42 : 26-37. 1988